Research & Development

Can Engineered BEVs Be the Next Weapon Against AMR?
Research & Development Can Engineered BEVs Be the Next Weapon Against AMR?

Relentless rises in drug-resistant infections have turned routine care into a negotiation with risk that standard antibiotics too often lose, and the search for smarter countermeasures has shifted to tools built by biology itself. Bacterial extracellular vesicles (BEVs) sit at that inflection

Do Ultra-Processed Foods Harm Us—or Their Nutrients?
Research & Development Do Ultra-Processed Foods Harm Us—or Their Nutrients?

The choice happens in a blink—flavored yogurt cup or plain yogurt with a drizzle of maple syrup—yet the metabolic ripples from that small moment could touch cholesterol, blood pressure, and insulin sensitivity before the month is out, and for millions such split-second picks may shape a decade of

Can miR-181d Revolutionize Glioblastoma Treatment?
Research & Development Can miR-181d Revolutionize Glioblastoma Treatment?

The diagnostic weight of Glioblastoma Multiforme has remained largely unchanged for decades, despite the rapid acceleration of genetic sequencing and molecular mapping in other oncology sectors. This malignancy represents the primary challenge in adult oncology due to its infiltrating nature and

Atomic Map of Vibrio Bacteria Helps Disarm Deadly Infections
Research & Development Atomic Map of Vibrio Bacteria Helps Disarm Deadly Infections

The warming of coastal waters along the Atlantic and Mediterranean has accelerated the proliferation of Vibrio bacteria, creating an urgent public health crisis that demands immediate scientific intervention. As these pathogens thrive in rising temperatures, traditional medical approaches find

Can Risk-Based Oversight Secure AI in Clinical Research?
Research & Development Can Risk-Based Oversight Secure AI in Clinical Research?

The rapid proliferation of computational intelligence in pharmaceutical development has reached a critical juncture where traditional manual oversight methods are struggling to keep pace with the speed of machine learning integration. On April 20, 2026, Advarra unveiled a comprehensive framework

Can Single-Cell AI Predict Cancer Patient Survival?
Research & Development Can Single-Cell AI Predict Cancer Patient Survival?

Modern oncology has long grappled with the frustrating reality that two patients with the exact same diagnosis can experience drastically different outcomes despite receiving identical treatments. This clinical mystery often stems from the hidden biological diversity within a single tumor, a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later